Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2022 Earnings

28AprConfirmed

Q3 2021

Q4 2021

Q1 2022

Q2 2022

-11.34

-10.15

-8.96

-7.77

Details

Expected EPS

-9.13493

Actual EPS

-9.8756

Surprise EPS

-0.74

Surprise Percent

+8.11%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -9.8756 per share for Q2 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.